Skip to main content
PPH logo
PPH
(NASDAQ)
VanEck Pharmaceutical ETF
$114.21-- (--)
Loading... - Market loading

PPH ETF: VanEck Pharmaceutical ETF - Price, Holdings & Analysis

VanEck Pharmaceutical ETF Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fund characteristics, expense ratio, dividend yield, and performance metrics

Day's Range$113.15 - $113.91
52-Week High$118.00
52-Week Low$85.91
Open$113.59
Volume272.07K
Average Volume (3M)246.52K
Assets (AUM)954.80M
Expense Ratio0.36%
Total Holdings26
Inception DateFeb 1, 2000
1 Day Change-0.39%
1 Month Change0.18%
6 Month Change1.72%
YTD Change9.54%
1 Year Change27.84%
52-Week Change28.53%
5 Year Change49.68%
10 Year Change91.22%
50-Day MA$110.61
200-Day MA$105.64
RSI52.43
Stochastic %K46.06
Stochastic %D57.14
Annual Dividend$3.31
Dividend Yield2.91%
Last Dividend Ex-DateOct 6, 2026
Dividend Growth YoY69.31%
Years Dividend Growth3

Frequently Asked Questions About VanEck Pharmaceutical ETF

What is the current price of PPH?

The latest PPH price is $113.62. The 52-week range is $85.91–$118.00. PPH has returned 28.5% over the past 52 weeks.

What is the expense ratio for PPH?

PPH's annual expense ratio is 0.36%. This represents the yearly cost of holding the fund, deducted from total returns. Compare with similar Equity ETFs in the ETF Screener.

Does PPH pay dividends?

Yes, PPH pays a 2.91% dividend yield. The last ex-dividend date was 2026-10-06. View full dividend history in the Dividends section.

What are the top holdings of PPH?

PPH's largest holdings are Eli Lilly and Company (22.9%), Novartis AG (10.5%), Novartis AG ADR (10.4%) (combined weight: 43.9%). The fund holds 26 total positions. View the complete portfolio breakdown in the Holdings section.

How does PPH compare to similar ETFs?

Compare PPH (0.36% expense ratio, $955M AUM) against similar Equity ETFs using the ETF Screener. Filter by expense ratio, dividend yield, and performance to find alternatives.